Monte Rosa Therapeutics is a biopharmaceutical company. Co. has developed a protein degradation platform, called QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates), to enable its target-centric approach to its molecular glue degraders (MGDs) discovery and development. Co.'s QuEEN platform enables it to identify protein targets and associated MGD product candidates that are designed to eliminate therapeutically-relevant proteins. Co.'s primary candidate, MRT-2359, is an orally bioavailable degrader of the translation termination factor protein GSPT1 in development initially for use in the treatment of cancers overexpressing one of the Myc family genes (c-Myc, N-Myc and L-Myc). We show 11 historical shares outstanding datapoints in our GLUE shares outstanding history coverage, used to compute GLUE market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing GLUE market cap history over the course of time is important for investors
interested in comparing GLUE's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of GLUE versus a peer is one thing; comparing
GLUE market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like GLUE can fluctuate over the course of history.
With this page we aim to empower investors researching GLUE by allowing them to research the GLUE market cap history. |
Free GLUE Email Alerts:
Video: The Importance of Market Cap
